<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36792609</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>23</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2041-4889</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Feb</Month><Day>15</Day></PubDate></JournalIssue><Title>Cell death &amp; disease</Title><ISOAbbreviation>Cell Death Dis</ISOAbbreviation></Journal><ArticleTitle>ERK1/2-dependent TSPO overactivation associates with the loss of mitophagy and mitochondrial respiration in ALS.</ArticleTitle><Pagination><StartPage>122</StartPage><MedlinePgn>122</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">122</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41419-023-05643-0</ELocationID><Abstract><AbstractText>Mitochondrial dysfunction and the loss of mitophagy, aimed at recycling irreversibly damaged organelles, contribute to the onset of amyotrophic lateral sclerosis (ALS), a fatal neurodegenerative disease affecting spinal cord motor neurons. In this work, we showed that the reduction of mitochondrial respiration, exactly oxygen flows linked to ATP production and maximal capacity, correlates with the appearance of the most common ALS motor symptoms in a transgenic mouse model expressing SOD1 G93A mutant. This is the result of the equal inhibition in the respiration linked to complex I and II of the electron transport chain, but not their protein levels. Since the overall mitochondrial mass was unvaried, we investigated the expression of the Translocator Protein (TSPO), a small mitochondrial protein whose overexpression was recently linked to the loss of mitophagy in a model of Parkinson's disease. Here we clearly showed that levels of TSPO are significantly increased in ALS mice. Mechanistically, this increase is linked to the overactivation of ERK1/2 pathway and correlates with a decrease in the expression of the mitophagy-related marker Atg12, indicating the occurrence of impairments in the activation of mitophagy. Overall, our work sets out TSPO as a key regulator of mitochondrial homeostasis in ALS.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Magr&#xec;</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Biological, Geological and Environmental Sciences, University of Catania, Catania, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>we.MitoBiotech S.R.L., C.so Italia 172, Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lipari</LastName><ForeName>Cristiana Lucia Rita</ForeName><Initials>CLR</Initials><AffiliationInfo><Affiliation>Department of Biomedical and Biotechnological Sciences, University of Catania, Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Risiglione</LastName><ForeName>Pierpaolo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Biomedical and Biotechnological Sciences, University of Catania, Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zimbone</LastName><ForeName>Stefania</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Istituto di Cristallografia, Consiglio Nazionale delle Ricerche, Section of Catania, Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guarino</LastName><ForeName>Francesca</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>we.MitoBiotech S.R.L., C.so Italia 172, Catania, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical and Biotechnological Sciences, University of Catania, Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caccamo</LastName><ForeName>Antonella</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Drug and Health Sciences, University of Catania, Catania, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Chemical, Biological, Pharmaceutical Sciences, University of Messina, Messina, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Messina</LastName><ForeName>Angela</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-5745-9846</Identifier><AffiliationInfo><Affiliation>Department of Biological, Geological and Environmental Sciences, University of Catania, Catania, Italy. mess@unict.it.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>we.MitoBiotech S.R.L., C.so Italia 172, Catania, Italy. mess@unict.it.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Cell Death Dis</MedlineTA><NlmUniqueID>101524092</NlmUniqueID></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D013482">Superoxide Dismutase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.24</RegistryNumber><NameOfSubstance UI="C000709408">Mapk3 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.24</RegistryNumber><NameOfSubstance UI="C535148">Mapk1 protein, mouse</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020935" MajorTopicYN="N">MAP Kinase Signaling System</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008928" MajorTopicYN="N">Mitochondria</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D063306" MajorTopicYN="N">Mitophagy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013116" MajorTopicYN="N">Spinal Cord</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013482" MajorTopicYN="N">Superoxide Dismutase</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>8</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>1</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>15</Day><Hour>23</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36792609</ArticleId><ArticleId IdType="pmc">PMC9931716</ArticleId><ArticleId IdType="doi">10.1038/s41419-023-05643-0</ArticleId><ArticleId IdType="pii">10.1038/s41419-023-05643-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Phukan J, Pender NP, Hardiman O. Cognitive impairment in amyotrophic lateral sclerosis. Lancet Neurol. 2007;6:994&#x2013;1003. doi: 10.1016/S1474-4422(07)70265-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(07)70265-X</ArticleId><ArticleId IdType="pubmed">17945153</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardiman O, Al-Chalabi A, Chio A, Corr EM, Logroscino G, Robberecht W, et al. Amyotrophic lateral sclerosis. Nat Rev Dis Prim. 2017;3:17071. doi: 10.1038/nrdp.2017.71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2017.71</ArticleId><ArticleId IdType="pubmed">28980624</ArticleId></ArticleIdList></Reference><Reference><Citation>van den Bos MAJ, Geevasinga N, Higashihara M, Menon P, Vucic S. Pathophysiology and diagnosis of ALS: insights from advances in neurophysiological techniques. Int J Mol Sci. 2019;20:2818. doi: 10.3390/ijms20112818.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20112818</ArticleId><ArticleId IdType="pmc">PMC6600525</ArticleId><ArticleId IdType="pubmed">31185581</ArticleId></ArticleIdList></Reference><Reference><Citation>Masrori P, van Damme P. Amyotrophic lateral sclerosis: a clinical review. Eur J Neurol. 2020;27:1918&#x2013;29. doi: 10.1111/ene.14393.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14393</ArticleId><ArticleId IdType="pmc">PMC7540334</ArticleId><ArticleId IdType="pubmed">32526057</ArticleId></ArticleIdList></Reference><Reference><Citation>Mejzini R, Flynn LL, Pitout IL, Fletcher S, Wilton SD, Akkari PA. ALS genetics, mechanisms, and therapeutics: where are we now? Front Neurosci. 2019;13:1310. doi: 10.3389/fnins.2019.01310.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.01310</ArticleId><ArticleId IdType="pmc">PMC6909825</ArticleId><ArticleId IdType="pubmed">31866818</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi A, Jones A, Troakes C, King A, Al-Sarraj S, van den Berg LH. The genetics and neuropathology of amyotrophic lateral sclerosis. Acta Neuropathol. 2012;124:339&#x2013;52. doi: 10.1007/s00401-012-1022-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-012-1022-4</ArticleId><ArticleId IdType="pubmed">22903397</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362:59&#x2013;62. doi: 10.1038/362059a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/362059a0</ArticleId><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>Edens BM, Miller N, Ma YC. Impaired autophagy and defective mitochondrial function: converging paths on the road to motor neuron degeneration. Front Cell Neurosci. 2016;10:44. doi: 10.3389/fncel.2016.00044.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2016.00044</ArticleId><ArticleId IdType="pmc">PMC4776126</ArticleId><ArticleId IdType="pubmed">26973461</ArticleId></ArticleIdList></Reference><Reference><Citation>Rizzuto R, De Stefani D, Raffaello A, Mammucari C. Mitochondria as sensors and regulators of calcium signalling. Nat Rev Mol Cell Biol. 2012;13:566&#x2013;78. doi: 10.1038/nrm3412.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm3412</ArticleId><ArticleId IdType="pubmed">22850819</ArticleId></ArticleIdList></Reference><Reference><Citation>Herst PM, Rowe MR, Carson GM, Berridge MV. Functional mitochondria in health and disease. Front Endocrinol. 2017;8:296. doi: 10.3389/fendo.2017.00296.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2017.00296</ArticleId><ArticleId IdType="pmc">PMC5675848</ArticleId><ArticleId IdType="pubmed">29163365</ArticleId></ArticleIdList></Reference><Reference><Citation>Payne BAI, Chinnery PF. Mitochondrial dysfunction in aging: Much progress but many unresolved questions. Biochim Biophys Acta Bioenerg. 2015;1847:1347&#x2013;53. doi: 10.1016/j.bbabio.2015.05.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbabio.2015.05.022</ArticleId><ArticleId IdType="pmc">PMC4580208</ArticleId><ArticleId IdType="pubmed">26050973</ArticleId></ArticleIdList></Reference><Reference><Citation>Zala D, Hinckelmann MV, Yu H, Lyra Da Cunha MM, Liot G, Cordeli&#xe8;res FP, et al. Vesicular glycolysis provides on-board energy for fast axonal transport. Cell. 2013;152:479&#x2013;91. doi: 10.1016/j.cell.2012.12.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2012.12.029</ArticleId><ArticleId IdType="pubmed">23374344</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaki S, Iwata M. Mitochondrial alterations in the spinal cord of patients with sporadic amyotrophic lateral sclerosis. Neuropathol Exp Neurol. 2007;66:10&#x2013;16. doi: 10.1097/nen.0b013e31802c396b.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/nen.0b013e31802c396b</ArticleId><ArticleId IdType="pubmed">17204932</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith EF, Shaw PJ, de Vos KJ. The role of mitochondria in amyotrophic lateral sclerosis. Neurosci Lett. 2019;710:132933. doi: 10.1016/j.neulet.2017.06.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2017.06.052</ArticleId><ArticleId IdType="pubmed">28669745</ArticleId></ArticleIdList></Reference><Reference><Citation>Coussee E, de Smet P, Bogaert E, Elens I, van Damme P, Willems P, et al. G37R SOD1 mutant alters mitochondrial complex I activity, Ca2+ uptake and ATP production. Cell Calcium. 2011;49:217&#x2013;25. doi: 10.1016/j.ceca.2011.02.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ceca.2011.02.004</ArticleId><ArticleId IdType="pubmed">21388680</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattiazzi M, D&#x2019;Aurelio M, Gajewski CD, Martushova K, Kiaei M, Flint Beal M, et al. Mutated human SOD1 causes dysfunction of oxidative phosphorylation in mitochondria of transgenic mice. J Biol Chem. 2002;277:29626&#x2013;33. doi: 10.1074/jbc.M203065200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M203065200</ArticleId><ArticleId IdType="pubmed">12050154</ArticleId></ArticleIdList></Reference><Reference><Citation>Magran&#xe9; J, Sahawneh MA, Przedborski S, Est&#xe9;vez &#xc1;G, Manfredi G. Mitochondrial dynamics and bioenergetic dysfunction is associated with synaptic alterations in mutant SOD1 motor neurons. J Neurosci. 2012;32:229&#x2013;42. doi: 10.1523/JNEUROSCI.1233-11.2012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1233-11.2012</ArticleId><ArticleId IdType="pmc">PMC3566782</ArticleId><ArticleId IdType="pubmed">22219285</ArticleId></ArticleIdList></Reference><Reference><Citation>Magran&#xe9; J, Hervias I, Henning MS, Damiano M, Kawamata H, Manfredi G. Mutant SOD1 in neuronal mitochondria causes toxicity and mitochondrial dynamics abnormalities. Hum Mol Gen. 2009;18:4552&#x2013;64. doi: 10.1093/hmg/ddp421.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddp421</ArticleId><ArticleId IdType="pmc">PMC2773270</ArticleId><ArticleId IdType="pubmed">19779023</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruijn LI, Houseweart MK, Kato S, Anderson KL, Anderson SD, Ohama E, et al. Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1. Science. 1998;281:1851&#x2013;4. doi: 10.1126/science.281.5384.1851.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.281.5384.1851</ArticleId><ArticleId IdType="pubmed">9743498</ArticleId></ArticleIdList></Reference><Reference><Citation>Tiwari A, Xu Z, Hayward LJ. Aberrantly increased hydrophobicity shared by mutants of Cu,Zn-superoxide dismutase in familial amyotrophic lateral sclerosis. J Biol Chem. 2005;280:29771&#x2013;9. doi: 10.1074/jbc.M504039200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M504039200</ArticleId><ArticleId IdType="pubmed">15958382</ArticleId></ArticleIdList></Reference><Reference><Citation>Huai J, Zhang Z. Structural properties and interaction partners of familial ALS-associated SOD1 mutants. Front Neurol. 2019;10:527. doi: 10.3389/fneur.2019.00527.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2019.00527</ArticleId><ArticleId IdType="pmc">PMC6536575</ArticleId><ArticleId IdType="pubmed">31164862</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw BF, Valentine JS. How do ALS-associated mutations in superoxide dismutase 1 promote aggregation of the protein? Trends Biochem Sci. 2007;32:78&#x2013;85. doi: 10.1016/j.tibs.2006.12.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tibs.2006.12.005</ArticleId><ArticleId IdType="pubmed">17208444</ArticleId></ArticleIdList></Reference><Reference><Citation>Sau D, de Biasi S, Vitellaro-Zuccarello L, Riso P, Guarnieri S, Porrini M, et al. Mutation of SOD1 in ALS: a gain of a loss of function. Hum Mol Genet. 2016;16:1604&#x2013;18. doi: 10.1093/hmg/ddm110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddm110</ArticleId><ArticleId IdType="pubmed">17504823</ArticleId></ArticleIdList></Reference><Reference><Citation>Vande Velde C, Miller TM, Cashman NR, Cleveland DW. Selective association of misfolded ALS-linked mutant SOD1 with the cytoplasmic face of mitochondria. Proc Natl Acad Sci USA. 2008;105:4022&#x2013;7. doi: 10.1073/pnas.0712209105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0712209105</ArticleId><ArticleId IdType="pmc">PMC2268797</ArticleId><ArticleId IdType="pubmed">18296640</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q, Velde CV, Israelson A, Xie J, Bailey AO, Dong MQ, et al. ALS-linked mutant superoxide dismutase 1 (SOD1) alters mitochondrial protein composition and decreases protein import. Proc Natl Acad Sci USA. 2010;107:21146&#x2013;51. doi: 10.1073/pnas.1014862107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1014862107</ArticleId><ArticleId IdType="pmc">PMC3000256</ArticleId><ArticleId IdType="pubmed">21078990</ArticleId></ArticleIdList></Reference><Reference><Citation>Israelson A, Arbel N, da Cruz S, Ilieva H, Yamanaka K, Shoshan-Barmatz V, et al. Misfolded mutant SOD1 directly inhibits VDAC1 conductance in a mouse model of inherited ALS. Neuron. 2010;67:575&#x2013;87. doi: 10.1016/j.neuron.2010.07.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2010.07.019</ArticleId><ArticleId IdType="pmc">PMC2941987</ArticleId><ArticleId IdType="pubmed">20797535</ArticleId></ArticleIdList></Reference><Reference><Citation>Magr&#xec; A, Belfiore R, Reina S, Tomasello MF, di Rosa MC, Guarino F, et al. Hexokinase I N-terminal based peptide prevents the VDAC1-SOD1 G93A interaction and re-establishes ALS cell viability. Sci Rep. 2016;6:34802. doi: 10.1038/srep34802.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep34802</ArticleId><ArticleId IdType="pmc">PMC5056396</ArticleId><ArticleId IdType="pubmed">27721436</ArticleId></ArticleIdList></Reference><Reference><Citation>Magr&#xec; A, Risiglione P, Caccamo A, Formicola B, Tomasello MF, Arrigoni C, et al. Small Hexokinase 1 peptide against toxic SOD1 G93A mitochondrial accumulation in ALS rescues the ATP-related respiration. Biomedicines. 2021;9:948. doi: 10.3390/biomedicines9080948.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines9080948</ArticleId><ArticleId IdType="pmc">PMC8392704</ArticleId><ArticleId IdType="pubmed">34440152</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasinelli P, Belford ME, Lennon N, Bacskai BJ, Hyman BT, Trotti D, et al. Amyotrophic lateral sclerosis-associated SOD1 mutant proteins bind and aggregate with Bcl-2 in spinal cord mitochondria. Neuron. 2004;43:19&#x2013;30. doi: 10.1016/j.neuron.2004.06.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2004.06.021</ArticleId><ArticleId IdType="pubmed">15233914</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamacher-Brady A, Brady NR. Mitophagy programs: mechanisms and physiological implications of mitochondrial targeting by autophagy. Cell Mol Life Sci. 2016;73:775&#x2013;95. doi: 10.1007/s00018-015-2087-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-015-2087-8</ArticleId><ArticleId IdType="pmc">PMC4735260</ArticleId><ArticleId IdType="pubmed">26611876</ArticleId></ArticleIdList></Reference><Reference><Citation>Ge P, Dawson VL, Dawson TM. PINK1 and Parkin mitochondrial quality control: a source of regional vulnerability in Parkinson&#x2019;s disease. Mol Neurodegener. 2020;15:20. doi: 10.1186/s13024-020-00367-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-020-00367-7</ArticleId><ArticleId IdType="pmc">PMC7071653</ArticleId><ArticleId IdType="pubmed">32169097</ArticleId></ArticleIdList></Reference><Reference><Citation>Maruyama H, Morino H, Ito H, Izumi Y, Kato H, Watanabe Y, et al. Mutations of optineurin in amyotrophic lateral sclerosis. Nature. 2010;465:233&#x2013;6. doi: 10.1038/nature08971.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature08971</ArticleId><ArticleId IdType="pubmed">20428114</ArticleId></ArticleIdList></Reference><Reference><Citation>Fecto F, Yan J, Vemula SP, Liu E, Yang Y, Chen W, et al. SQSTM1 mutations in familial and sporadic amyotrophic lateral sclerosis. Arch Neurol. 2011;68:1440&#x2013;6. doi: 10.1001/archneurol.2011.250.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneurol.2011.250</ArticleId><ArticleId IdType="pubmed">22084127</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Zhou B, Lin MY, Wang S, Foust KD, Sheng ZH. Endolysosomal deficits augment mitochondria pathology in spinal motor neurons of asymptomatic fALS mice. Neuron. 2015;87:355&#x2013;70. doi: 10.1016/j.neuron.2015.06.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2015.06.026</ArticleId><ArticleId IdType="pmc">PMC4511489</ArticleId><ArticleId IdType="pubmed">26182418</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong K, Li Y, Duan W, Guo Y, Jiang H, Li W, et al. Full-length TDP-43 and its C-terminal fragments activate mitophagy in NSC34 cell line. Neurosci Lett. 2012;530:144&#x2013;9. doi: 10.1016/j.neulet.2012.10.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2012.10.003</ArticleId><ArticleId IdType="pubmed">23063673</ArticleId></ArticleIdList></Reference><Reference><Citation>Cha SJ, Choi HJ, Kim HJ, Choi EJ, Song KH, Im DS, et al. Parkin expression reverses mitochondrial dysfunction in fused in sarcoma-induced amyotrophic lateral sclerosis. Insect Mol Biol. 2020;29:56&#x2013;65. doi: 10.1111/imb.12608.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imb.12608</ArticleId><ArticleId IdType="pubmed">31290213</ArticleId></ArticleIdList></Reference><Reference><Citation>Frison M, Faccenda D, Abeti R, Rigon M, Strobbe D, England-Rendon BS, et al. The translocator protein (TSPO) is prodromal to mitophagy loss in neurotoxicity. Mol Psychiatry. 2021;26:2721&#x2013;39. doi: 10.1038/s41380-021-01050-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-021-01050-z</ArticleId><ArticleId IdType="pmc">PMC8505241</ArticleId><ArticleId IdType="pubmed">33664474</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerhard A. TSPO imaging in parkinsonian disorders. Clin Transl Imaging. 2016;4:183&#x2013;90. doi: 10.1007/s40336-016-0171-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40336-016-0171-1</ArticleId><ArticleId IdType="pmc">PMC4870295</ArticleId><ArticleId IdType="pubmed">27340650</ArticleId></ArticleIdList></Reference><Reference><Citation>Batarseh A, Li J, Papadopoulos V. Protein kinase C&#x3b5; regulation of translocator protein (18 kDa) Tspo gene expression is mediated through a MAPK pathway targeting STAT3 and c-Jun transcription factors. Biochemistry. 2010;49:4766&#x2013;78. doi: 10.1021/bi100020e.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi100020e</ArticleId><ArticleId IdType="pmc">PMC2902160</ArticleId><ArticleId IdType="pubmed">20469933</ArticleId></ArticleIdList></Reference><Reference><Citation>Wooley CM, Sher RB, Kale A, Frankel WN, Cox GA, Seburn KL. Gait analysis detects early changes in transgenic SOD1(G93A) mice. Muscle Nerve. 2005;32:43&#x2013;50. doi: 10.1002/mus.20228.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.20228</ArticleId><ArticleId IdType="pmc">PMC1350398</ArticleId><ArticleId IdType="pubmed">15880561</ArticleId></ArticleIdList></Reference><Reference><Citation>Gnaiger E. Capacity of oxidative phosphorylation in human skeletal muscle. New perspectives of mitochondrial physiology. Int J Biochem Cell Biol. 2009;41:1837&#x2013;45. doi: 10.1016/j.biocel.2009.03.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biocel.2009.03.013</ArticleId><ArticleId IdType="pubmed">19467914</ArticleId></ArticleIdList></Reference><Reference><Citation>Cacabelos D, Ram&#xed;rez-N&#xfa;&#xf1;ez O, Granado-Serrano AB, Torres P, Ayala V, Moiseeva V, et al. Early and gender-specific differences in spinal cord mitochondrial function and oxidative stress markers in a mouse model of ALS. Acta Neuropathol Commun. 2016;4:3. doi: 10.1186/s40478-015-0271-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-015-0271-6</ArticleId><ArticleId IdType="pmc">PMC4711180</ArticleId><ArticleId IdType="pubmed">26757991</ArticleId></ArticleIdList></Reference><Reference><Citation>Finley LWS, Haas W, Desquiret-Dumas V, Wallace DC, Procaccio V, Gygi SP, et al. Succinate dehydrogenase is a direct target of Sirtuin 3 deacetylase activity. PLoS ONE. 2011;6:e23295. doi: 10.1371/journal.pone.0023295.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0023295</ArticleId><ArticleId IdType="pmc">PMC3157345</ArticleId><ArticleId IdType="pubmed">21858060</ArticleId></ArticleIdList></Reference><Reference><Citation>Lavisse S, Goutal S, Wimberley C, Tonietto M, Bottlaender M, Gervais P, et al. Increased microglial activation in patients with Parkinson disease using [18F]-DPA714 TSPO PET imaging. Parkinsonism Relat Disord. 2021;82:29&#x2013;36. doi: 10.1016/j.parkreldis.2020.11.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.parkreldis.2020.11.011</ArticleId><ArticleId IdType="pubmed">33242662</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanada T, Noda NN, Satomi Y, Ichimura Y, Fujioka Y, Takao T, et al. The Atg12-Atg5 conjugate has a novel E3-like activity for protein lipidation in autophagy. J Biol Chem. 2007;282:37298&#x2013;302. doi: 10.1074/jbc.C700195200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.C700195200</ArticleId><ArticleId IdType="pubmed">17986448</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahu R, Upadhayay S, Mehan S. Inhibition of extracellular regulated kinase (ERK)-1/2 signaling pathway in the prevention of ALS: target inhibitors and influences on neurological dysfunctions. Eur J Cell Biol. 2021;100:151179. doi: 10.1016/j.ejcb.2021.151179.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejcb.2021.151179</ArticleId><ArticleId IdType="pubmed">34560374</ArticleId></ArticleIdList></Reference><Reference><Citation>Gautam M, Gunay A, Chandel NS, Ozdinler PH. Mitochondrial dysregulation occurs early in ALS motor cortex with TDP-43 pathology and suggests maintaining NAD+ balance as a therapeutic strategy. Sci Rep. 2022;12:4287. doi: 10.1038/s41598-022-08068-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-08068-5</ArticleId><ArticleId IdType="pmc">PMC8917163</ArticleId><ArticleId IdType="pubmed">35277554</ArticleId></ArticleIdList></Reference><Reference><Citation>Myoung JC, Suh YL. Ultrastructural changes of mitochondria in the skeletal muscle of patients with amyotrophic lateral sclerosis. Ultrastruct Pathol. 2002;26:3&#x2013;7. doi: 10.1080/01913120252934260.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/01913120252934260</ArticleId><ArticleId IdType="pubmed">12028652</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi AMK, Ryter SW, Levine B. Autophagy in human health and disease. N Engl J Med. 2013;368:651&#x2013;62. doi: 10.1056/NEJMra1205406.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1205406</ArticleId><ArticleId IdType="pubmed">23406030</ArticleId></ArticleIdList></Reference><Reference><Citation>Marchetti P, Fovez Q, Germain N, Khamari R, Kluza J. Mitochondrial spare respiratory capacity: mechanisms, regulation, and significance in non-transformed and cancer cells. FASEB J. 2020;34:13106&#x2013;24. doi: 10.1096/fj.202000767R.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.202000767R</ArticleId><ArticleId IdType="pubmed">32808332</ArticleId></ArticleIdList></Reference><Reference><Citation>Risiglione P, Cubisino SAM, Lipari CLR, De Pinto V, Messina A, Magr&#xec; A. &#x3b1;-synuclein A53T promotes mitochondrial proton gradient dissipation and depletion of the organelle respiratory reserve in a neuroblastoma cell line. Life. 2022;12:894. doi: 10.3390/life12060894.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/life12060894</ArticleId><ArticleId IdType="pmc">PMC9225574</ArticleId><ArticleId IdType="pubmed">35743925</ArticleId></ArticleIdList></Reference><Reference><Citation>Risiglione P, Leggio L, Cubisino SAM, Reina S, Patern&#xf2; G, Marchetti B, et al. High-resolution respirometry reveals MPP+ mitochondrial toxicity mechanism in a cellular model of Parkinson&#x2019;s disease. Int J Mol Sci. 2020;21:7809. doi: 10.3390/ijms21217809.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21217809</ArticleId><ArticleId IdType="pmc">PMC7659480</ArticleId><ArticleId IdType="pubmed">33105548</ArticleId></ArticleIdList></Reference><Reference><Citation>Leggio L, L&#x2019;episcopo F, Magr&#xec; A, Ulloa-Navas J, Patern&#xf2; G, Vivarelli S, et al. Small extracellular vesicles secreted by nigrostriatal astrocytes rescue cell death and preserve mitochondrial function in Parkinson&#x2019;s disease. Adv Healthc Mater. 2022;11:2201203. doi: 10.1002/adhm.202201203.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/adhm.202201203</ArticleId><ArticleId IdType="pubmed">35856921</ArticleId></ArticleIdList></Reference><Reference><Citation>Browne SE, Bowling AC, Baik MJ, Gurney M, Brown RH, Beal MF. Metabolic dysfunction in familial, but not sporadic, amyotrophic lateral sclerosis. J Neurochem. 1998;71:281&#x2013;7. doi: 10.1046/j.1471-4159.1998.71010281.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1471-4159.1998.71010281.x</ArticleId><ArticleId IdType="pubmed">9648876</ArticleId></ArticleIdList></Reference><Reference><Citation>Magr&#xec; A, Messina A. Interactions of VDAC with proteins involved in neurodegenerative aggregation: an opportunity for advancement on therapeutic molecules. Curr Med Chem. 2017;24:4470&#x2013;87. doi: 10.2174/0929867324666170601073920.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/0929867324666170601073920</ArticleId><ArticleId IdType="pubmed">28571556</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, Lillo C, Jonsson PA, Vande Velde C, Ward CM, Miller TM, et al. Toxicity of familial ALS-linked SOD1 mutants from selective recruitment to spinal mitochondria. Neuron. 2004;43:5&#x2013;17. doi: 10.1016/j.neuron.2004.06.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2004.06.016</ArticleId><ArticleId IdType="pubmed">15233913</ArticleId></ArticleIdList></Reference><Reference><Citation>Ansari A, Rahman MS, Saha SK, Saikot FK, Deep A, Kim KH. Function of the SIRT3 mitochondrial deacetylase in cellular physiology, cancer, and neurodegenerative disease. Aging Cell. 2017;16:4&#x2013;16. doi: 10.1111/acel.12538.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/acel.12538</ArticleId><ArticleId IdType="pmc">PMC5242307</ArticleId><ArticleId IdType="pubmed">27686535</ArticleId></ArticleIdList></Reference><Reference><Citation>Lombard DB, Alt FW, Cheng H-L, Bunkenborg J, Streeper RS, Mostoslavsky R, et al. Mammalian Sir2 homolog SIRT3 regulates global mitochondrial lysine acetylation. Mol Cell Biol. 2007;27:8807&#x2013;14. doi: 10.1128/MCB.01636-07.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.01636-07</ArticleId><ArticleId IdType="pmc">PMC2169418</ArticleId><ArticleId IdType="pubmed">17923681</ArticleId></ArticleIdList></Reference><Reference><Citation>Hor JH, Santosa MM, Lim VJW, Ho BX, Taylor A, Khong ZJ, et al. ALS motor neurons exhibit hallmark metabolic defects that are rescued by SIRT3 activation. Cell Death Differ. 2021;28:1379&#x2013;97. doi: 10.1038/s41418-020-00664-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41418-020-00664-0</ArticleId><ArticleId IdType="pmc">PMC8027637</ArticleId><ArticleId IdType="pubmed">33184465</ArticleId></ArticleIdList></Reference><Reference><Citation>Papadopoulos V, Baraldi M, Guilarte TR, Knudsen TB, Lacap&#xe8;re JJ, Lindemann P, et al. Translocator protein (18 kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. Trends Pharm Sci. 2006;27:402&#x2013;9. doi: 10.1016/j.tips.2006.06.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tips.2006.06.005</ArticleId><ArticleId IdType="pubmed">16822554</ArticleId></ArticleIdList></Reference><Reference><Citation>Veenman L, Papadopoulos V, Gavish M. Channel-like functions of the 18-kDa Translocator Protein (TSPO): regulation of apoptosis and steroidogenesis as part of the host-defense response. Curr Pharm Des. 2007;13:2385&#x2013;405. doi: 10.2174/138161207781368710.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/138161207781368710</ArticleId><ArticleId IdType="pubmed">17692008</ArticleId></ArticleIdList></Reference><Reference><Citation>Caballero B, Veenman L, Gavish M. Role of mitochondrial Translocator Protein (18 kDa) on mitochondrial-related cell death processes. Recent Pat Endocr Metab Immune Drug Disco. 2013;7:86&#x2013;101. doi: 10.2174/1872214811307020002.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1872214811307020002</ArticleId><ArticleId IdType="pubmed">23368281</ArticleId></ArticleIdList></Reference><Reference><Citation>Edison P, Archer HA, Gerhard A, Hinz R, Pavese N, Turkheimer FE, et al. Microglia, amyloid, and cognition in Alzheimer&#x2019;s disease: an [11C](R)PK11195-PET and [11C]PIB-PET study. Neurobiol Dis. 2008;32:412&#x2013;9. doi: 10.1016/j.nbd.2008.08.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2008.08.001</ArticleId><ArticleId IdType="pubmed">18786637</ArticleId></ArticleIdList></Reference><Reference><Citation>Pannell M, Economopoulos V, Wilson TC, Kersemans V, Isenegger PG, Larkin JR, et al. Imaging of translocator protein upregulation is selective for pro-inflammatory polarized astrocytes and microglia. Glia. 2020;68:280&#x2013;97. doi: 10.1002/glia.23716.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.23716</ArticleId><ArticleId IdType="pmc">PMC6916298</ArticleId><ArticleId IdType="pubmed">31479168</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner MR, Cagnin A, Turkheimer FE, Miller CCJ, Shaw CE, Brooks DJ, et al. Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: An [11C](R)-PK11195 positron emission tomography study. Neurobiol Dis. 2004;15:601&#x2013;9. doi: 10.1016/j.nbd.2003.12.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2003.12.012</ArticleId><ArticleId IdType="pubmed">15056468</ArticleId></ArticleIdList></Reference><Reference><Citation>James ML, Belichenko NP, Nguyen TV, Andrews LE, Ding Z, Liu H, et al. PET imaging of translocator protein (18 kDa) in a mouse model of Alzheimer&#x2019;s disease using N-(2,5-dimethoxybenzyl)-2-18F-fluoro-N-(2-phenoxyphenyl)acetamide. J Nucl Med. 2015;56:311&#x2013;6. doi: 10.2967/jnumed.114.141648.</Citation><ArticleIdList><ArticleId IdType="doi">10.2967/jnumed.114.141648</ArticleId><ArticleId IdType="pmc">PMC4866832</ArticleId><ArticleId IdType="pubmed">25613536</ArticleId></ArticleIdList></Reference><Reference><Citation>Daugherty DJ, Selvaraj V, Chechneva OV, Liu XB, Pleasure DE, Deng WA. TSPO ligand is protective in a mouse model of multiple sclerosis. EMBO Mol Med. 2013;5:891&#x2013;903. doi: 10.1002/emmm.201202124.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/emmm.201202124</ArticleId><ArticleId IdType="pmc">PMC3779450</ArticleId><ArticleId IdType="pubmed">23681668</ArticleId></ArticleIdList></Reference><Reference><Citation>Mai S, Muster B, Bereiter-Hahn J, Jendrach M. Autophagy proteins LC3B, ATG5 and ATG12 participate in quality control after mitochondrial damage and influence life span. Autophagy. 2012;8:47&#x2013;62. doi: 10.4161/auto.8.1.18174.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/auto.8.1.18174</ArticleId><ArticleId IdType="pmc">PMC3335991</ArticleId><ArticleId IdType="pubmed">22170153</ArticleId></ArticleIdList></Reference><Reference><Citation>Lavoie H, Gagnon J, Therrien M. ERK signalling: a master regulator of cell behaviour, life and fate. Nat Rev Mol Cell Biol. 2020;21:607&#x2013;32. doi: 10.1038/s41580-020-0255-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41580-020-0255-7</ArticleId><ArticleId IdType="pubmed">32576977</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayala V, Granado-Serrano AB, Cacabelos D, Naud&#xed; A, Ilieva EV, Boada J, et al. Cell stress induces TDP-43 pathological changes associated with ERK1/2 dysfunction: Implications in ALS. Acta Neuropathol. 2011;122:259&#x2013;70. doi: 10.1007/s00401-011-0850-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-011-0850-y</ArticleId><ArticleId IdType="pubmed">21706176</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitra J, Hegde PM, Hegde ML. Loss of endosomal recycling factor RAB11 coupled with complex regulation of MAPK/ERK/AKT signaling in postmortem spinal cord specimens of sporadic amyotrophic lateral sclerosis patients. Mol Brain. 2019;12:55. doi: 10.1186/s13041-019-0475-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13041-019-0475-y</ArticleId><ArticleId IdType="pmc">PMC6567394</ArticleId><ArticleId IdType="pubmed">31196199</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoon HC, Kyeung MJ, Heon CL, Mi HC, Kim D, Won BL, et al. Immunohistochemical study on the distribution of phosphorylated extracellular signal-regulated kinase (ERK) in the central nervous system of SOD1G93A transgenic mice. Brain Res. 2005;1050:203&#x2013;9. doi: 10.1016/j.brainres.2005.05.060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2005.05.060</ArticleId><ArticleId IdType="pubmed">15978558</ArticleId></ArticleIdList></Reference><Reference><Citation>Nowak G, Clifton GL, Godwin ML, Bakajsova D. Activation of ERK1/2 pathway mediates oxidant-induced decreases in mitochondrial function in renal cells. Am J Physiol Ren Physiol. 2006;291:F840&#x2013;F855. doi: 10.1152/ajprenal.00219.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajprenal.00219.2005</ArticleId><ArticleId IdType="pmc">PMC1978509</ArticleId><ArticleId IdType="pubmed">16705147</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, Alexander DD, et al. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science. 1994;264:1772&#x2013;5. doi: 10.1126/science.8209258.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.8209258</ArticleId><ArticleId IdType="pubmed">8209258</ArticleId></ArticleIdList></Reference><Reference><Citation>Caccamo A, Magr&#xed; A, Oddo S. Age-dependent changes in TDP-43 levels in a mouse model of Alzheimer disease are linked to A&#x3b2; oligomers accumulation. Mol Neurodegener. 2010;5:51. doi: 10.1186/1750-1326-5-51.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1326-5-51</ArticleId><ArticleId IdType="pmc">PMC2989316</ArticleId><ArticleId IdType="pubmed">21070634</ArticleId></ArticleIdList></Reference><Reference><Citation>Caccamo A, Magr&#xec; A, Medina DX, Wisely EV, L&#xf3;pez-Aranda MF, Silva AJ, et al. mTOR regulates tau phosphorylation and degradation: implications for Alzheimer&#x2019;s disease and other tauopathies. Aging Cell. 2013;12:370&#x2013;80. doi: 10.1111/acel.12057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/acel.12057</ArticleId><ArticleId IdType="pmc">PMC3655115</ArticleId><ArticleId IdType="pubmed">23425014</ArticleId></ArticleIdList></Reference><Reference><Citation>Cant&#xf3; C, Garcia-Roves PM. High-resolution respirometry for mitochondrial characterization of ex vivo mouse tissues. Curr Protoc Mouse Biol. 2015;5:135&#x2013;53. doi: 10.1002/9780470942390.mo140061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/9780470942390.mo140061</ArticleId><ArticleId IdType="pubmed">26069081</ArticleId></ArticleIdList></Reference><Reference><Citation>Gnaiger E, Kuznetsov AV. Mitochondrial respiration at low levels of oxygen and cytochrome c. Biochem Soc Trans. 2002;30:252&#x2013;8. doi: 10.1042/bst0300252.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/bst0300252</ArticleId><ArticleId IdType="pubmed">12023860</ArticleId></ArticleIdList></Reference><Reference><Citation>Pesta D, Gnaiger E. High-resolution respirometry: OXPHOS protocols for human cells and permeabilized fibers from small biopsies of human muscle. Methods Mol Biol. 2012;810:25&#x2013;58. doi: 10.1007/978-1-61779-382-0_3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-61779-382-0_3</ArticleId><ArticleId IdType="pubmed">22057559</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>